IN THE HOSPITAL & AT HOME
The Volara™ System offers 3-in-1 Oscillation and Lung Expansion (OLE) therapy for airway clearance, with proven1 outcomes and game-changing versatility.
Providing continuity of care.
The Volara™ System is an OLE device indicated for the mobilization of secretions, lung expansion therapy, and the treatment and prevention of pulmonary atelectasis. Proven1 in the acute care setting to deliver outstanding clinical and economic outcomes, the ease of use of OLE now extends across the hospital and in the home with this versatile system.
Continuous Positive Expiratory Pressure treats and helps prevent pulmonary atelectasis by combining continuous positive pressure with aerosol medication, to help expand and hold the airways open.
Continuous High Frequency Oscillation, a pneumatic form of chest therapy, delivers continuous pulses of positive pressure combined with aerosol medication to mobilize and treat retained secretions.
Integrated with CPEP and CHFO for maximum treatment efficiency, medication is delivered during therapy to help loosen secretions.
Watch how.
Watch how.
See how this practical and flexible system has the power to change lives, with 3-in-1 OLE therapy that takes just 10 minutes to deliver.
In the hospital, for a wide range of settings:
- Trauma/emergency room
- Post-op
- Intensive care
- Geriatric
- Bariatric
- Pediatric
At home, for chronic conditions:
- Cystic Fibrosis (CF)
- Cerebral palsy (CP)
- Amyotrophic lateral sclerosis (ALS)
- Muscular dystrophy (MD)
- Spinal muscular atrophy (SMA)
- Spinal cord injuries (SCI)
The Volara™ System is an OLE (Oscillation and Lung Expansion) device that uniquely delivers three treatments – CPEP, CHFO and Nebulizer with exciting advancements for accurate, consistent therapy in acute and chronic care settings.
Intuitive touchscreen interface
Broad range of circuit adaptors
Lightweight and portable
Physician-prescribed presets
Dual power source
By the numbers.
Tested and proven1 in acute care settings—and now also for the home with the Volara™ System—OLE therapy has been shown to provide outstanding clinical outcomes.
Reduction in hospital length of stay1
Reduction in time on ventilator1
Reduction in ICU length of stay1
Overall relative reduction in postoperative pulmonary complications.1
Have a question about the Volara™ System?
- Huynh TT, Liesching TN, Cereda M, Lei Y, Frazer MJ, Nahouraii MR, Diette GB, Efficacy of Oscillation and Lung Expansion in Reducing Postoperative Pulmonary Complication, Journal of the American College of Surgeons (2019).